Search

Your search keyword '"David Viswanatha"' showing total 35 results

Search Constraints

Start Over You searched for: Author "David Viswanatha" Remove constraint Author: "David Viswanatha"
35 results on '"David Viswanatha"'

Search Results

1. U2AF1 pathogenic variants in myeloid neoplasms and precursor states: distribution of co-mutations and prognostic heterogeneity

2. Prospective evaluation of genome sequencing to compare conventional cytogenetics in acute myeloid leukemia

3. Observation and treatment in DDX41-mutated acute myeloid leukemia and myelodysplastic syndrome

4. P580: CHARACTERISTICS AND OUTCOMES OF PATIENTS WITH WT1 MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

5. P722: CHARACTERISATION OF PHF6 MUTATIONS IN MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

6. P747: CLINICAL CHARACTERISTICS AND OUTCOME OF EZH2-MUTATED MYELOID NEOPLASMS: MAYO CLINIC EXPERIENCE

7. P734: CLONAL HEIRARCHY AND HETEROGENEITY IN STAG2M MYELOID NEOPLASMS: THE MAYO CLINIC EXPERIENCE

9. Clinical and molecular correlates of somatic and germline DDX41 variants in patients and families with myeloid neoplasms

10. Adverse karyotype subcategories in acute myeloid leukemia display significant differences in mutation composition and transplant-augmented survival

11. Clinical and biological characteristics and prognostic impact of somatic GATA2 mutations in myeloid malignancies: a single institution experience

13. Mayo Clinic experience with 1123 adults with acute myeloid leukemia

14. Myeloid malignancies with 5q and 7q deletions are associated with extreme genomic complexity, biallelic TP53 variants, and very poor prognosis

15. Daunorubicin-60 versus daunorubicin-90 versus idarubicin-12 for induction chemotherapy in acute myeloid leukemia: a retrospective analysis of the Mayo Clinic experience

16. DNMT3A R882 Mutations Confer Unique Clinicopathologic Features in MDS Including a High Risk of AML Transformation

20. Autoimmune manifestations in STAG2-mutated myeloid neoplasms

21. Comparison between GATA2 and DDX41-mutated myeloid neoplasms

22. Co-mutational pattern of somatic GATA2-mutated myeloid neoplasms

23. A dynamic 3-factor survival model for acute myeloid leukemia that accounts for response to induction chemotherapy

24. Abnormal CD13/HLA-DR Expression Pattern on Myeloblasts Predicts Development of Myeloid Neoplasia in Patients With Clonal Cytopenia of Undetermined Significance

25. Characteristics and prognosis of DDX41- and GATA2-mutated myeloid neoplasms

26. Characteristics and prognosis of mutated STAG2 myeloid neoplasms

27. 48. Crowdsourcing expert curation of somatic variants by the ClinGen Somatic Hematologic Cancer Taskforce

28. Defining Lymphoplasmacytic Lymphoma: Does MYD88L265P Define a Pathologically Distinct Entity Among Patients With an IgM Paraprotein and Bone Marrow-Based Low-Grade B-Cell Lymphomas With Plasmacytic Differentiation?

29. MYD88 mutation status does not impact overall survival in Waldenström macroglobulinemia

30. Nonsecretory Variant of Immunoproliferative Small Intestinal Disease: A Case Report With Pathologic, Immunophenotypic, and Molecular Findings

31. Laboratory practice guidelines for detecting and reporting BCR-ABL drug resistance mutations in chronic myelogenous leukemia and acute lymphoblastic leukemia: a report of the Association for Molecular Pathology

32. Peripheral T-cell lymphoma with extensive dendritic cell network mimicking follicular dendritic cell tumor: a case report with pathologic, immunophenotypic, and molecular findings

33. Usefulness of the dissecting microscope in the surgical management of skin cancers

34. Isolated Trisomy 15: A Clonal Chromosome Abnormality in Bone Marrow With Doubtful Hematologic Significance.

Catalog

Books, media, physical & digital resources